A Study of Baricitinib in Healthy Participants
Clinical trial NCT03212638 · COMPLETED
Trial details
- NCT number
- NCT03212638
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2017-07-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.